{"id":"https://openalex.org/W7225329026","doi":"https://doi.org/10.1039/d6ra06159a","title":"ExNCDIA: an explainable ensemble learning framework for predicting non-chemotherapy drug-induced agranulocytosis and interpreting structural associations","display_name":"ExNCDIA: an explainable ensemble learning framework for predicting non-chemotherapy drug-induced agranulocytosis and interpreting structural associations","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7225329026","doi":"https://doi.org/10.1039/d6ra06159a","pmid":"https://pubmed.ncbi.nlm.nih.gov/42991828","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13736793"},"language":"en","primary_location":{"id":"doi:10.1039/d6ra06159a","doi":"https://doi.org/10.1039/d6ra06159a","is_oa":true,"landing_page_url":"https://doi.org/10.1039/d6ra06159a","pdf_url":null,"source":{"id":"https://openalex.org/S2481244646","display_name":"RSC Advances","issn_l":"2046-2069","issn":["2046-2069"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RSC Advances","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1039/d6ra06159a","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005945462","display_name":"Huang Xiao-jie","orcid":"https://orcid.org/0000-0002-9510-2899","observed_orcids":["https://orcid.org/0000-0002-9510-2899"]},"institutions":[{"id":"https://openalex.org/I4405267623","display_name":"Jieyang People's Hospital","ror":"https://ror.org/03mpy3k07","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4405267623"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Xiaojie Huang","raw_affiliation_strings":["Department of Pharmacy, Jieyang People's Hospital, Jieyang 522000, China"],"raw_orcid":"https://orcid.org/0000-0002-9510-2899","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Jieyang People's Hospital, Jieyang 522000, China","institution_ids":["https://openalex.org/I4405267623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085257104","display_name":"Shusong Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267623","display_name":"Jieyang People's Hospital","ror":"https://ror.org/03mpy3k07","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4405267623"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shusong Jiang","raw_affiliation_strings":["Department of Pharmacy, Jieyang People's Hospital, Jieyang 522000, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Jieyang People's Hospital, Jieyang 522000, China","institution_ids":["https://openalex.org/I4405267623"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5130315995","display_name":"Peineng Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267623","display_name":"Jieyang People's Hospital","ror":"https://ror.org/03mpy3k07","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4405267623"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peineng Liu","raw_affiliation_strings":["Department of Pharmacy, Jieyang People's Hospital, Jieyang 522000, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Jieyang People's Hospital, Jieyang 522000, China","institution_ids":["https://openalex.org/I4405267623"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5005945462"],"corresponding_institution_ids":["https://openalex.org/I4405267623"],"apc_list":{"value":850,"currency":"GBP","value_usd":1042},"apc_paid":{"value":850,"currency":"GBP","value_usd":1042},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.79515665,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiosyncratic-drug-toxicity","display_name":"idiosyncratic drug toxicity","score":0.9580000042915344},{"id":"https://openalex.org/keywords/explainable-machine-learning","display_name":"explainable machine learning","score":0.8399999737739563},{"id":"https://openalex.org/keywords/ensemble-classifiers","display_name":"ensemble classifiers","score":0.5770000219345093},{"id":"https://openalex.org/keywords/random-forest","display_name":"random forest","score":0.7900000214576721},{"id":"https://openalex.org/keywords/shap","display_name":"SHAP","score":0.8460000157356262},{"id":"https://openalex.org/keywords/molecular-descriptors","display_name":"molecular descriptors","score":0.8460000157356262},{"id":"https://openalex.org/keywords/rdkit-descriptors","display_name":"RDKit descriptors","score":0.6380000114440918},{"id":"https://openalex.org/keywords/genetic-algorithm-feature-selection","display_name":"genetic algorithm feature selection","score":0.8500000238418579},{"id":"https://openalex.org/keywords/reactive-metabolites","display_name":"reactive metabolites","score":0.7839999794960022},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.8569999933242798},{"id":"https://openalex.org/keywords/myeloperoxidase","display_name":"myeloperoxidase","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pharmacophore","display_name":"pharmacophore","score":0.6940000057220459},{"id":"https://openalex.org/keywords/drug-safety-assessment","display_name":"drug safety assessment","score":0.5440000295639038},{"id":"https://openalex.org/keywords/web-based-tool","display_name":"web-based tool","score":0.4180000126361847}],"concepts":[{"id":"https://openalex.org/C45942800","wikidata":"https://www.wikidata.org/wiki/Q245652","display_name":"Ensemble learning","level":2,"score":0.7457000017166138},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.5814999938011169},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.5088000297546387},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.5038999915122986},{"id":"https://openalex.org/C119898033","wikidata":"https://www.wikidata.org/wiki/Q3433888","display_name":"Ensemble forecasting","level":2,"score":0.400299996137619},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3700000047683716},{"id":"https://openalex.org/C180747234","wikidata":"https://www.wikidata.org/wiki/Q23373","display_name":"Cognitive psychology","level":1,"score":0.2637999951839447},{"id":"https://openalex.org/C204321447","wikidata":"https://www.wikidata.org/wiki/Q30642","display_name":"Natural language processing","level":1,"score":0.24320000410079956},{"id":"https://openalex.org/C26517878","wikidata":"https://www.wikidata.org/wiki/Q228039","display_name":"Key (lock)","level":2,"score":0.22130000591278076},{"id":"https://openalex.org/C153180895","wikidata":"https://www.wikidata.org/wiki/Q7148389","display_name":"Pattern recognition (psychology)","level":2,"score":0.21660000085830688}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1039/d6ra06159a","doi":"https://doi.org/10.1039/d6ra06159a","is_oa":true,"landing_page_url":"https://doi.org/10.1039/d6ra06159a","pdf_url":null,"source":{"id":"https://openalex.org/S2481244646","display_name":"RSC Advances","issn_l":"2046-2069","issn":["2046-2069"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RSC Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13736793","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13736793/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13736793/pdf/RA-OLF-D6RA06159A.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RSC Adv","raw_type":"Text"},{"id":"pmid:42991828","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42991828","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RSC advances","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1039/d6ra06159a","doi":"https://doi.org/10.1039/d6ra06159a","is_oa":true,"landing_page_url":"https://doi.org/10.1039/d6ra06159a","pdf_url":null,"source":{"id":"https://openalex.org/S2481244646","display_name":"RSC Advances","issn_l":"2046-2069","issn":["2046-2069"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RSC Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320335376","display_name":"Medical Science and Technology Foundation of Guangdong Province","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225329026.pdf","grobid_xml":"https://content.openalex.org/works/W7225329026.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W1678356000","https://openalex.org/W1965584529","https://openalex.org/W1982348242","https://openalex.org/W1988037271","https://openalex.org/W1996090950","https://openalex.org/W2002337209","https://openalex.org/W2004080797","https://openalex.org/W2015870870","https://openalex.org/W2034549041","https://openalex.org/W2066273100","https://openalex.org/W2075221169","https://openalex.org/W2086507981","https://openalex.org/W2103392332","https://openalex.org/W2104167780","https://openalex.org/W2105649494","https://openalex.org/W2110235919","https://openalex.org/W2117819606","https://openalex.org/W2118561568","https://openalex.org/W2121891611","https://openalex.org/W2125434647","https://openalex.org/W2145578524","https://openalex.org/W2149134901","https://openalex.org/W2155261478","https://openalex.org/W2157480172","https://openalex.org/W2169303530","https://openalex.org/W2169737900","https://openalex.org/W2200017991","https://openalex.org/W2295598076","https://openalex.org/W2319097181","https://openalex.org/W2338318698","https://openalex.org/W2346582185","https://openalex.org/W2616891418","https://openalex.org/W2620760558","https://openalex.org/W2746036611","https://openalex.org/W2752212867","https://openalex.org/W2777107507","https://openalex.org/W2791355014","https://openalex.org/W2809395091","https://openalex.org/W2891385203","https://openalex.org/W2973941913","https://openalex.org/W2999309192","https://openalex.org/W3099758073","https://openalex.org/W3112550610","https://openalex.org/W3194955687","https://openalex.org/W4244209983","https://openalex.org/W4248107770","https://openalex.org/W4296162381","https://openalex.org/W4310774636","https://openalex.org/W4378070318","https://openalex.org/W4401592149","https://openalex.org/W4406279793","https://openalex.org/W4406817467","https://openalex.org/W4407096622","https://openalex.org/W4408219803","https://openalex.org/W4412066478","https://openalex.org/W4414299103","https://openalex.org/W7140043546","https://openalex.org/W7158589894"],"related_works":["https://openalex.org/W4401592149","https://openalex.org/W7167408985","https://openalex.org/W7160893266","https://openalex.org/W7225175291","https://openalex.org/W7223134051","https://openalex.org/W7171967156","https://openalex.org/W6946281441","https://openalex.org/W6885117774","https://openalex.org/W7166889650","https://openalex.org/W7125229554"],"abstract_inverted_index":{"Non-chemotherapy":[0],"drug-induced":[1],"agranulocytosis":[2],"(NCDIA)":[3],"is":[4],"a":[5,17,85,201],"rare":[6],"but":[7],"life-threatening":[8],"idiosyncratic":[9],"toxicity":[10],"whose":[11],"mechanisms":[12],"remain":[13,54],"largely":[14],"unresolved;":[15],"for":[16,60],"subset":[18],"of":[19,88],"drugs,":[20],"however,":[21],"the":[22,48,127,147,164],"risk":[23,169,220],"has":[24],"been":[25],"linked":[26],"to":[27,43,157,181,187],"chemical":[28,82],"structure":[29],"through":[30],"bioactivation,":[31],"whereby":[32],"reactive":[33,188],"intermediates":[34],"injure":[35],"neutrophils":[36],"and":[37,40,57,93,101,105,145,177,184,218],"myeloid":[38],"progenitors,":[39],"haptenate":[41],"proteins":[42],"trigger":[44],"immune-mediated":[45],"destruction.":[46],"Yet":[47],"structural":[49,212],"features":[50],"underlying":[51],"this":[52],"liability":[53,79],"poorly":[55],"defined,":[56],"interpretable":[58,211],"models":[59],"flagging":[61],"it":[62],"during":[63],"design":[64],"are":[65],"scarce.":[66],"Here":[67],"we":[68,96],"report":[69],"ExNCDIA,":[70],"an":[71],"explainable":[72],"machine":[73],"learning":[74],"framework":[75],"that":[76],"predicts":[77],"NCDIA":[78,168],"directly":[80],"from":[81],"structure.":[83],"From":[84],"curated":[86],"set":[87],"906":[89],"drugs":[90],"(371":[91],"NCDIA-positive":[92],"535":[94],"NCDIA-negative),":[95],"benchmarked":[97],"complementary":[98],"open-source":[99],"representations":[100,161],"imbalance-aware":[102],"ensemble":[103],"classifiers,":[104],"retained":[106],"two":[107,159],"balanced":[108,140],"random":[109],"forest":[110],"models-one":[111],"trained":[112],"on":[113,129,146,163],"RDKit":[114],"molecular":[115],"descriptors":[116],"refined":[117],"by":[118],"genetic-algorithm":[119],"feature":[120],"selection":[121],"(test":[122,133],"ROC-AUC":[123,134],"0.850,":[124],"MCC":[125,136],"0.591),":[126],"other":[128],"MACCS":[130],"substructure":[131],"keys":[132],"0.847,":[135],"0.518).":[137],"Both":[138],"showed":[139],"discrimination":[141],"in":[142],"training-set":[143],"cross-validation":[144],"held-out":[148],"test":[149],"set.":[150],"Crucially,":[151],"Shapley":[152],"additive":[153],"explanations":[154],"(SHAP)":[155],"applied":[156],"these":[158],"non-overlapping":[160],"converged":[162],"same":[165],"medicinal-chemistry":[166],"signal:":[167],"rises":[170],"with":[171,191,210],"sulfur-containing":[172],"pharmacophores,":[173],"multiple":[174],"aromatic":[175],"rings,":[176],"nitrogen-bearing/arylamine":[178],"cores-motifs":[179],"prone":[180],"cytochrome":[182],"P450-":[183],"myeloperoxidase-mediated":[185],"oxidation":[186],"metabolites-and":[189],"falls":[190],"aliphatic,":[192],"saturated-oxygenated":[193],"scaffolds":[194],"lacking":[195],"such":[196],"bioactivatable":[197],"groups.":[198],"Delivered":[199],"as":[200],"freely":[202],"accessible":[203],"web":[204],"tool,":[205],"ExNCDIA":[206],"couples":[207],"quantitative":[208],"prediction":[209],"associations,":[213],"supporting":[214],"early":[215],"candidate":[216],"prioritization":[217],"post-marketing":[219],"assessment.":[221]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-06T00:00:00"}
